Traditional Chinese Medicine Monomers: Targeting Pulmonary Artery Smooth Muscle Cells Proliferation to Treat Pulmonary Hypertension

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 May 2

PMID 37128338

Authors

Xiuli Yang

Yang Yang

Ke Liu

Chuantao Zhang

Affiliations

Soon will be listed here.

Abstract

Pulmonary hypertension (PH) is a complex multifactorial disease characterized by increased pulmonary vascular resistance and pulmonary vascular remodeling (PVR), with high morbidity, disability, and mortality. The abnormal proliferation of pulmonary artery smooth muscle cells (PASMCs) is the main pathological change causing PVR. At present, clinical treatment drugs for PH are limited, which can only improve symptoms and reduce hospitalization but cannot delay disease progression and reduce survival rate. In recent years, numerous studies have shown that traditional Chinese medicine monomers (TCMs) inhibit excessive proliferation of PASMCs resulting in alleviating PVR through multiple channels and multiple targets, which has attracted more and more attention in the treatment of PH. In this paper, the experimental evidence of inhibiting PASMCs proliferation by TCMs was summarized to provide some directions for the future development of these mentioned TCMs as anti-PH drugs in clinical.

Citing Articles

Mechanism of action of aloperine in the treatment of pulmonary arterial hypertension based on network pharmacology and molecular docking methods.

Wang Y, Yan B, Ma P, Zhou R, Zhao F Herz. 2025; .

PMID: 40055190 DOI: 10.1007/s00059-025-05295-0.

Zhishi Xiebai Guizhi Decoction modulates hypoxia and lipid toxicity to alleviate pulmonary vascular remodeling of pulmonary hypertension in rats.

Fu M, Li Y, Liu J, Liu J, Wei J, Qiao Y Chin Med. 2024; 19(1):173.

PMID: 39696593 PMC: 11657759. DOI: 10.1186/s13020-024-01039-0.

T follicular helper cell is essential for M2 macrophage polarization and pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.

Li C, Liu P, Zhu H, Yang H, Zha J, Yao H Respir Res. 2024; 25(1):428.

PMID: 39633343 PMC: 11619207. DOI: 10.1186/s12931-024-03058-9.

References

Lu L, Qin Y, Chen C, Guo X . Beneficial Effects Exerted by Paeonol in the Management of Atherosclerosis. Oxid Med Cell Longev. 2018; 2018:1098617. PMC: 6247470. DOI: 10.1155/2018/1098617. View

Feng W, Ao H, Peng C, Yan D . Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019; 142:176-191. DOI: 10.1016/j.phrs.2019.02.024. View

Li Z, Qiao W, Wang C, Wang H, Ma M, Han X . DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment. Drug Deliv. 2020; 27(1):736-744. PMC: 7269040. DOI: 10.1080/10717544.2020.1760962. View

Ahmad B, Khan S, Liu Y, Xue M, Nabi G, Kumar S . Molecular Mechanisms of Anticancer Activities of Puerarin. Cancer Manag Res. 2020; 12:79-90. PMC: 6956866. DOI: 10.2147/CMAR.S233567. View

Morales-Cano D, Menendez C, Moreno E, Moral-Sanz J, Barreira B, Galindo P . The flavonoid quercetin reverses pulmonary hypertension in rats. PLoS One. 2014; 9(12):e114492. PMC: 4252144. DOI: 10.1371/journal.pone.0114492. View

Wang R, He R, Jiao H, Dai M, Mu Y, Hu Y . Ginsenoside Rb1 attenuates agonist-induced contractile response via inhibition of store-operated calcium entry in pulmonary arteries of normal and pulmonary hypertensive rats. Cell Physiol Biochem. 2015; 35(4):1467-81. DOI: 10.1159/000373966. View

Feng J, Zheng T, Hou Z, Lv C, Xue A, Han T . Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo. Oncol Rep. 2020; 44(5):2231-2240. DOI: 10.3892/or.2020.7781. View

Li M, Jiang D, Wang Y, Chen Q, Ma Y, Yu S . Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol. 2015; 67(2):182-90. DOI: 10.1097/FJC.0000000000000328. View

Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A . Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. N Engl J Med. 2021; 384(4):325-334. DOI: 10.1056/NEJMoa2008470. View

10.

Dhoble S, Patravale V . SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension. AAPS PharmSciTech. 2022; 23(5):158. DOI: 10.1208/s12249-022-02312-x. View

11.

Sun Q, Gong T, Liu M, Ren S, Yang H, Zeng S . Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches. Phytomedicine. 2021; 94:153805. DOI: 10.1016/j.phymed.2021.153805. View

12.

Jayasuriya H, Koonchanok N, Geahlen R, McLaughlin J, Chang C . Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J Nat Prod. 1992; 55(5):696-8. DOI: 10.1021/np50083a026. View

13.

Mansouri Z, Dianat M, Radan M, Badavi M . Ellagic Acid Ameliorates Lung Inflammation and Heart Oxidative Stress in Elastase-Induced Emphysema Model in Rat. Inflammation. 2020; 43(3):1143-1156. DOI: 10.1007/s10753-020-01201-4. View

14.

Wang F, Chen J, Xiang D, Lian X, Wu C, Quan J . Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway. Am J Transl Res. 2020; 12(5):2295-2304. PMC: 7270036. View

15.

Sitbon O, Channick R, Chin K, Frey A, Gaine S, Galie N . Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2015; 373(26):2522-33. DOI: 10.1056/NEJMoa1503184. View

16.

Dong F, Zhang J, Zhu S, Lan T, Yang J, Li L . Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells. J Cardiovasc Pharmacol. 2019; 74(5):426-435. DOI: 10.1097/FJC.0000000000000726. View

17.

Huang H, Kong L, Luan S, Qi C, Wu F . Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway. Am J Chin Med. 2021; 49(2):437-459. DOI: 10.1142/S0192415X21500208. View

18.

Zhu T, Zhang W, Luo P, He F, Ge X, Zhang Z . Epigallocatechin-3-gallate ameliorates hypoxia-induced pulmonary vascular remodeling by promoting mitofusin-2-mediated mitochondrial fusion. Eur J Pharmacol. 2017; 809:42-51. DOI: 10.1016/j.ejphar.2017.05.003. View

19.

Wang L, Wang Y, Lei Z . Chrysin ameliorates ANTU-induced pulmonary edema and pulmonary arterial hypertension via modulation of VEGF and eNOs. J Biochem Mol Toxicol. 2019; 33(7):e22332. DOI: 10.1002/jbt.22332. View

20.

Wande Y, Jie L, Aikai Z, Yaguo Z, Linlin Z, Yue G . Berberine alleviates pulmonary hypertension through Trx1 and β-catenin signaling pathways in pulmonary artery smooth muscle cells. Exp Cell Res. 2020; 390(1):111910. DOI: 10.1016/j.yexcr.2020.111910. View